These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 475410)

  • 1. Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.
    Hughes IA; Wilton A; Lole CA; Gray OP
    Arch Dis Child; 1979 May; 54(5):350-5. PubMed ID: 475410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity in the management of congenital adrenal hyperplasia.
    Griffiths KD; Anderson JM; Rudd BT; Virdi NK; Holder G; Rayner PH
    Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
    Limal JM; Rappaport R; Bayard F
    J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
    [No Abstract]   [Full Text] [Related]  

  • 4. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA; Winter JS
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia: renin and steroid values during treatment.
    Grant DB; Dillon MJ; Atherden SM; Levinsky RJ
    Eur J Pediatr; 1977 Aug; 126(1-2):86-96. PubMed ID: 902665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I; Cutler GB
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Horner JM; Hintz RL; Luetscher JA
    J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT; Raux MC; Gourmelen M; Baron MC; Girard F
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [9-alpha-fluorocortisol in the treatment of congenital adrenal hyperplasia with salt loss].
    de Filippo P; Tomasi L; Cirillo B
    Pediatria (Napoli); 1978 Mar; 86(1):77-88. PubMed ID: 683796
    [No Abstract]   [Full Text] [Related]  

  • 10. Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy.
    Hughes IA; Winter JS
    Can Med Assoc J; 1977 Aug; 117(4):363-5. PubMed ID: 890632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia and hyperreninemic hypoaldosteronism in a critically ill patient: combination of insensitivity to angiotensin II and tubular unresponsiveness to mineralocorticoid.
    Muto S; Fujisawa G; Natsume T; Asano Y; Yaginuma T; Hosoda S; Saito T
    Clin Nephrol; 1990 Nov; 34(5):208-13. PubMed ID: 2176579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia.
    Sólyom J; Gaál K
    Acta Paediatr Acad Sci Hung; 1979; 20(2-3):229-35. PubMed ID: 397714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
    Hughes IA; Winter JS
    J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma 17OH-progesterone concentrations in newborn infants.
    Hughes IA; Riad-Fahmy D; Griffiths K
    Arch Dis Child; 1979 May; 54(5):347-9. PubMed ID: 475409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
    Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
    Quinkler M; Oelkers W; Remde H; Allolio B
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
    Koshimizu T
    Clin Endocrinol (Oxf); 1979 May; 10(5):515-22. PubMed ID: 225066
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency.
    Mullis PE; Hindmarsh PC; Brook CG
    Eur J Pediatr; 1990 Nov; 150(1):22-5. PubMed ID: 2079072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia responsive to fludrocortisone acetate in elderly patients after head injury.
    Ishikawa SE; Saito T; Kaneko K; Okada K; Kuzuya T
    Ann Intern Med; 1987 Feb; 106(2):187-91. PubMed ID: 3800181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.